R.A. Figlin: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

51

Combined cytoreductive laser therapy and immunotherapy for palliation of metastatic renal cell carcinoma to the head and neck

M. B. Paiva, J. A. Sercarz, A. J. Pantuck, M. Polyakov, R. A. Figlin, R. F. Canalis, D. J. Castro

Journal:

Lasers in Medical Science

Year:

2007

Language:

english

File:

PDF, 112 KB

english, 2007

52

Targeted therapies for renal cell carcinoma: understanding their impact on survival

Sumanta Kumar Pal, Robert A. Figlin

Journal:

Targeted Oncology

Year:

2010

Language:

english

File:

PDF, 169 KB

english, 2010

53

Future directions of mammalian target of rapamycin (mTOR) inhibitor therapy in renal cell carcinoma

Sumanta Kumar Pal, Robert A. Figlin

Journal:

Targeted Oncology

Year:

2011

Language:

english

File:

PDF, 323 KB

english, 2011

54

G250: A carbonic anhydrase IX monoclonal antibody

John S. Lam, Allan J. Pantuck, Arie S. Belldegrun, Robert A. Figlin

Journal:

Current Oncology Reports

Year:

2005

Language:

english

File:

PDF, 396 KB

english, 2005

55

Dendritic cell-based immunotherapy of renal cell carcinoma

Barbara J. Gitlitz, Robert A. Figlin, Allan J. Pantuck, Arie S. Belldegrun

Journal:

Current Urology Reports

Year:

2001

Language:

english

File:

PDF, 281 KB

english, 2001

56

Heat shock-peptide complex vaccine as adjuvant therapy for high-risk patients with resected renal cell carcinoma

Oleg Shvarts, John Lam, Robert Figlin, Arie S. Belldegrun

Journal:

Current Urology Reports

Year:

2004

Language:

english

File:

PDF, 126 KB

english, 2004

57

Surveillance following radical or partial nephrectomy for renal cell carcinoma

John S. Lam, John T. Leppert, Robert A. Figlin, Arie S. Belldegrun

Journal:

Current Urology Reports

Year:

2005

Language:

english

File:

PDF, 849 KB

english, 2005

58

Effect of temsirolimus versus interferon-α on outcome of patients with advanced renal cell carcinoma of different tumor histologies

Janice P. Dutcher, Paul de Souza, David McDermott, Robert A. Figlin, Anna Berkenblit, Alexandra Thiele, Mizue Krygowski, Andrew Strahs, Jay Feingold, Gary Hudes

Journal:

Medical Oncology

Year:

2009

Language:

english

File:

PDF, 253 KB

english, 2009

59

Different lymphoid cell populations produce varied levels of neopterin, β2-microglobulin and soluble IL-2 receptor when stimulated with IL-2, interferon-gamma or tumour necrosis factor-alpha

B. HOFMANN, H. BASS, P. NISHANIAN, M. FAISAL, R. A. FIGLIN, G. P. SARNA, J. L. FAHEY

Journal:

Clinical & Experimental Immunology

Year:

1992

Language:

english

File:

PDF, 647 KB

english, 1992

60

Carbonic anhydrase IX and the future of molecular markers in renal cell carcinoma

John T. Leppert, John S. Lam, Allan J. Pantuck, Robert A. Figlin, Arie S. Belldegrun

Journal:

BJU International

Year:

2005

Language:

english

File:

PDF, 337 KB

english, 2005

61

Adjuvant therapy of renal cell carcinoma: patient selection and therapeutic options

John S. Lam, John T. Leppert, Arie S. Belldegrun, Robert A. Figlin

Journal:

BJU International

Year:

2005

Language:

english

File:

PDF, 90 KB

english, 2005

62

Prognostic relevance of capsular involvement and collecting system invasion in stage I and II renal cell carcinoma

Tobias Klatte, JinSoo Chung, John T. Leppert, John S. Lam, Allan J. Pantuck, Robert A. Figlin, Arie S. Belldegrun

Journal:

BJU International

Year:

2007

Language:

english

File:

PDF, 97 KB

english, 2007

63

The role of molecular markers in the staging of renal cell carcinoma

John T. Leppert, Allan J. Pantuck, Robert A. Figlin, Arie S. Belldegrun

Journal:

BJU International

Year:

2007

Language:

english

File:

PDF, 84 KB

english, 2007

64

Economic evaluation of new targeted therapies for the first-line treatment of patients with metastatic renal cell carcinoma

Ágnes Benedict, Robert A. Figlin, Per Sandström, Ulrika Harmenberg, Anders Ullén, Claudie Charbonneau, Rickard Sandin, Edit Remák, Subramanian Hariharan, Sylvie Négrier

Journal:

BJU International

Year:

2011

Language:

english

File:

PDF, 378 KB

english, 2011

65

Joint association of polymorphism of the FGFR4 gene and mutation TP53 gene with bladder cancer prognosis

Yang, Y C, Lu, M L, Rao, J Y, Wallerand, H, Cai, L, Cao, W, Pantuck, A, Dalbagni, G, Reuter, V, Figlin, R A

Journal:

British Journal of Cancer

Year:

2006

Language:

english

File:

PDF, 121 KB

english, 2006

66

Phase II study of intravenous adenosine 5'-triphosphate in patients with previously untreated stage IIIB and Stage IV non-small cell lung cancer

Charles M. Haskell, Evelyn Mendoza, Katherine M.W. Pisters, Frank V. Fossella, Robert A. Figlin

Journal:

Investigational New Drugs

Year:

1998

Language:

english

File:

PDF, 69 KB

english, 1998

67

A Phase II Pilot Study of KW-2189 in Patients with Advanced Renal Cell Carcinoma

Eric J. Small, Robert Figlin, Daniel Petrylak, David J. Vaughn, Oliver Sartor, Ivan Horak, Rosemarie Pincus, Alton Kremer, Chris Bowden

Journal:

Investigational New Drugs

Year:

2000

Language:

english

File:

PDF, 52 KB

english, 2000

68

Renal Cell Carcinoma Volume 528 || VEGF: Biologic Aspects and Clinical Approaches

Bukowski, Ronald M., Figlin, Robert A., Motzer, Robert J.

Year:

2009

Language:

english

File:

PDF, 282 KB

english, 2009

69

Two phase 2 trials of the novel Akt inhibitor perifosine in patients with advanced renal cell carcinoma after progression on vascular endothelial growth factor-targeted therapy

Daniel C. Cho, Thomas E. Hutson, Wolfram Samlowski, Peter Sportelli, Brad Somer, Paul Richards, Jeffrey A. Sosman, Igor Puzanov, M. Dror Michaelson, Keith T. Flaherty, Robert A. Figlin, Nicholas J. Vo

Journal:

Year:

2012

Language:

english

File:

PDF, 201 KB

english, 2012

70

Selective decrease in Leu8-negative T cell subpopulations following treatment with recombinant interferon-α2a (rIFN-α2a)

Otoniel Martínez-Maza, Robert A. Figlin, Janis V. Giorgi, John L. Fahey

Journal:

Cellular Immunology

Year:

1988

Language:

english

File:

PDF, 745 KB

english, 1988

71

Prognostic Factors in Renal Cell Carcinoma

Brian M. Shuch, John S. Lam, Arie S. Belldegrun, Robert A. Figlin

Journal:

Seminars in Oncology

Year:

2006

Language:

english

File:

PDF, 208 KB

english, 2006

72

Mammalian Target of Rapamycin Inhibitors in Renal Cell Carcinoma: Current Status and Future Applications

Allan J. Pantuck, George Thomas, Arie S. Belldegrun, Robert A. Figlin

Journal:

Seminars in Oncology

Year:

2006

Language:

english

File:

PDF, 415 KB

english, 2006

73

Renal Cell Carcinoma: The Translation of Biology to Clinical Application

Robert A. Figlin

Journal:

Seminars in Oncology

Year:

2006

Language:

english

File:

PDF, 66 KB

english, 2006

74

Fluorouracil does not enhance the limited effectiveness of subcutaneous recombinant interleukin-2 and recombinant interferon alfa-2a for metastatic renal cancer

Journal:

Evidence-based Oncology

Year:

2001

Language:

english

File:

PDF, 171 KB

english, 2001

75

CXCR4 expression on circulating pan-cytokeratin positive cells is associated with survival in patients with advanced non-small cell lung cancer

Karen L Reckamp, Robert A Figlin, Marie D Burdick, Steven M Dubinett, Robert M Elashoff, Robert M Strieter

Journal:

Year:

2009

Language:

english

File:

PDF, 1.78 MB

english, 2009

76

Current management of renal cell carcinoma

Dr. Mitchell H. Sokoloff, Dr. Jean B. Dekernion, Dr. Robert A. Figlin, Dr. Arie Belldegrun

Journal:

CA: A Cancer Journal for Clinicians

Year:

1996

Language:

english

File:

PDF, 299 KB

english, 1996

77

Phase I Trial of Sunitinib Malate plus Interferon-α for Patients with Metastatic Renal Cell Carcinoma

Robert J. Motzer, Gary Hudes, George Wilding, Lawrence H. Schwartz, Subramanian Hariharan, Susan Kempin, Rana Fayyad, Robert A. Figlin

Journal:

Clinical Genitourinary Cancer

Year:

2009

Language:

english

File:

PDF, 130 KB

english, 2009

78

Renal Cell Carcinoma Volume 344 || Vaccine-Based Immunotherapy and Targeting the Tumor Microenvironment in Renal Cell Carcinoma

Figlin, Robert A., Rathmell, W. Kimryn, Rini, Brian I.

Year:

2012

Language:

english

File:

PDF, 378 KB

english, 2012

79

Patterns of Cytokine Release of Unselected and CD8+ Selected Renal Cell Carcinoma Tumor-Infiltrating Lymphocytes (TIL): Evidence for Enhanced Specific Killing of Tumor Necrosis Factor-Secreting/IL-6 Nonsecreting TIL in Vitro and Correlation with Complete Response in Vivo

Günther G. Steger, William C. Pierce, Robert Figlin, Johannes Czernin, Randhie Kaboo, Jean B. deKernion, Thomas Okarma, Arie Belldegrun

Journal:

Clinical Immunology and Immunopathology

Year:

1994

File:

PDF, 688 KB

1994

80

Re: Allogeneic transplantation after nonmyelosuppressive conditioning—the effect of single-agent pentostatin

Gary J. Schiller, Rose Malone, Robert Figlin

Journal:

Biology of Blood and Marrow Transplantation

Year:

2004

Language:

english

File:

PDF, 56 KB

english, 2004

81

Multifaceted roles of cyclooxygenase-2 in lung cancer

Karen Riedl, Kostyantyn Krysan, Mehis Põld, Harnisha Dalwadi, Nathalie Heuze-Vourc’h, Mariam Dohadwala, Ming Liu, Xiaoyan Cui, Robert Figlin, Jenny T Mao, Robert Strieter, Sherven Sharma, Steven M Dub

Journal:

Drug Resistance Updates

Year:

2004

Language:

english

File:

PDF, 259 KB

english, 2004

82

Everolimus in metastatic renal cell carcinoma: Subgroup analysis of patients with 1 or 2 previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies enrolled in the phase III RECORD-1 study

E. Calvo, B. Escudier, R.J. Motzer, S. Oudard, T.E. Hutson, C. Porta, S. Bracarda, V. Grünwald, J.A. Thompson, A. Ravaud, D. Kim, A. Panneerselvam, O. Anak, R.A. Figlin

Journal:

European Journal of Cancer

Year:

2012

Language:

english

File:

PDF, 262 KB

english, 2012

83

Use of American Society of Anesthesiologists physical status classification to assess perioperative risk in patients undergoing radical nephrectomy for renal cell carcinoma

Ken-ryu Han, Hyung L. Kim, Allan J. Pantuck, Frederick J. Dorey, Robert A. Figlin, Arie S. Belldegrun

Journal:

Year:

2004

Language:

english

File:

PDF, 122 KB

english, 2004

84

Role of molecular markers in the diagnosis and therapy of renal cell carcinoma

John S. Lam, John T. Leppert, Robert A. Figlin, Arie S. Belldegrun

Journal:

Year:

2005

Language:

english

File:

PDF, 283 KB

english, 2005

85

RENCA/carbonic anhydrase-IX: A murine model of a carbonic anhydrase-IX-expressing renal cell carcinoma

Oleg Shvarts, Nicolette Janzen, John S. Lam, John T. Leppert, Randy Caliliw, Robert A. Figlin, Arie S. Belldegrun, Gang Zeng

Journal:

Year:

2006

Language:

english

File:

PDF, 3.90 MB

english, 2006

86

MP-19.13: A multicenter, randomized, phase III trial of a novel autologous therapeutic vaccine (vitespen) vs. observation as adjuvant therapy in patients at high risk of recurrence after nephrectomy for renal cell carcinoma

C. Wood, B. Escudier, L. Lacombe, A. Hoos, R. Gupta, R. Flanigan, R. Figlin, P. Srivastava

Journal:

Year:

2006

Language:

english

File:

PDF, 68 KB

english, 2006

87

Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection

A.J Pantuck, A Zisman, F Dorey, D.H Chao, K.R Han, J Said, B.J Gitlitz, R.A Figlin, A.S Belldegrun

Journal:

Urologic Oncology: Seminars and Original Investigations

Year:

2004

Language:

english

File:

PDF, 23 KB

english, 2004

88

Renal cell carcinoma with retroperitoneal lymph nodes. Impact on survival and benefits of immunotherapy

A.J Pantuck, A Zisman, F Dorey, D.H Chao, K.R Han, J Said, B Gitlitz, A.S Belldegrun, R.A Figlin

Journal:

Urologic Oncology: Seminars and Original Investigations

Year:

2004

Language:

english

File:

PDF, 22 KB

english, 2004

89

Number of metastatic sites rather than location dictates overall survival of patients with node-negative metastatic renal cell carcinoma

Ken-Ryu Han, Allan J Pantuck, Matthew H.T Bui, Oleg Shvarts, Danielo G Freitas, Amnon Zisman, Bradley C Leibovich, Frederick J Dorey, Barbara J Gitlitz, Robert A Figlin, Arie S Belldegrun

Journal:

Year:

2003

Language:

english

File:

PDF, 121 KB

english, 2003

90

Correlation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinoma

Harri Visapää, Matthew Bui, Yunda Huang, David Seligson, Henry Tsai, Allan Pantuck, Robert Figlin, Jian Y.u Rao, Arie Belldegrun, Steve Horvath, Aarno Palotie

Journal:

Year:

2003

Language:

english

File:

PDF, 236 KB

english, 2003

91

Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

Robert J Motzer, Bernard Escudier, Stéphane Oudard, Thomas E Hutson, Camillo Porta, Sergio Bracarda, Viktor Grünwald, John A Thompson, Robert A Figlin, Norbert Hollaender, Gladys Urbanowitz, William J

Journal:

Year:

2008

Language:

english

File:

PDF, 197 KB

english, 2008

92

1139 POSTER Asthenia and Fatigue as Potential Biomarkers of Sunitinib Efficacy in Metastatic Renal Cell Carcinoma

M.P. Davis, R.A. Figlin, T.E. Hutson, D. Goldstein, S. Li, J. Perkins, R.J. Motzer

Journal:

European Journal of Cancer

Year:

2011

Language:

english

File:

PDF, 42 KB

english, 2011

93

1301 POSTER Assessment of Progression-free Survival as a Surrogate Endpoint for Overall Survival in Patients With Metastatic Renal Cell Carcinoma

S. Neqrier, A.G. Bushmakin, J.C. Cappelleri, C. Charbonneau, R. Sandin, M.D. Michaelson, R.A. Figlin, R.J. Motzer

Journal:

European Journal of Cancer

Year:

2011

Language:

english

File:

PDF, 43 KB

english, 2011

94

3036 POSTER Comparison of Health-related Quality of Life (HRQoL) In Patients Reporting the Same Adverse Event (AE) Fatigue on Different Treatments

D. Cella, A.G. Bushmakin, J.C. Cappelleri, C. Charbonneau, R. Sandin, S. Negrier, R.A. Figlin, M.D. Michaelson, M.R. Davis, R.J. Motzer

Journal:

European Journal of Cancer

Year:

2011

Language:

english

File:

PDF, 42 KB

english, 2011

95

Cellular therapy of renal cell carcinoma past, present, future

Robert Figlin, Peter Mulders, Barbara Gitlitz, Arie Belldegrun

Journal:

European Journal of Cancer

Year:

1997

Language:

english

File:

PDF, 115 KB

english, 1997

96

Infusional interleukin-2 and 5-fluorouracil with subcutaneous interferon-α for the treatment of patients with advanced renal cell carcinoma: a Southwest Oncology Group phase II study.

L Elias, D Lew, RA Figlin, RC Flanigan, ME Thompson, PL Triozzi, RJ Belt, DP Wood, SE Rivkin, ED Crawford

Journal:

Urologic Oncology: Seminars and Original Investigations

Year:

2002

Language:

english

File:

PDF, 66 KB

english, 2002

97

Interleukin 2 Gene Therapy for Prostate Cancer: Phase I Clinical Trial and Basic Biology

Belldegrun, Arie, Tso, Cho-Lea, Zisman, Amnon, Naitoh, John, Said, Jonathan, Pantuck, Allan J., Hinkel, Andreas, deKernion, Jean, Figlin, Robert

Journal:

Human Gene Therapy

Year:

2001

Language:

english

File:

PDF, 497 KB

english, 2001

98

300 A COMPARISON OF KU0063794, A DUAL MTORC1 AND MTORC2 INHIBITOR, AND TEMSIROLIMUS IN PRECLINICAL RENAL CELL CARCINOMA MODELS

Zhang, Hao, Berel, Dror, Wang, Yanping, Figlin, Robert, Kim, Hyung

Journal:

The Journal of Urology

Year:

2012

Language:

english

File:

PDF, 199 KB

english, 2012

99

O-150 A phase II study of SGN-15 (cBR96-doxorubicin immunoconjugate) combined with docetaxel in patients with advanced stage or metastatic non-small cell lung cancer (NSCLC)

Ross, Helen, Rudin, Charles M., Figlin, Robert A., Hart, Lowell, Rarick, Mark, Jacobs, Andrew, Grove, Laurie, Sandler, Andrew S., Siegall, Clay, Sing, Amy P.

Journal:

Year:

2003

Language:

english

File:

PDF, 188 KB

english, 2003

100

O-287 Phase 2 study of TLK286 (GST P1-1 activated glutathione analog) administered weekly in patients with platinum refractory of resistant non-small cell lung cancer (NSCLC)

Papadimitrakopoulou, Vassiliki, Blumenschein, George, Fossella, Frank, Figlin, Robert, Gilitz, Barbara, Garland, Linda, Von Hoff, Daniel, King, Lisa, Jameson, Anneliese, Brown, Gail L.

Journal:

Year:

2003

Language:

english

File:

PDF, 376 KB

english, 2003

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски